| Bioactivity | LU9 is a potent 3CLpro inhibitor with an IC50 value of 0.34 µM. LU9 has the potential for the research of SARS-CoV-2[1]. |
| Target | IC50: 0.34 µM (3CLpro) |
| Formula | C22H29Cl2N9O4 |
| Molar Mass | 554.43 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Wang X, et al. Covalent DNA-Encoded Library Workflow Drives Discovery of SARS-CoV-2 Nonstructural Protein Inhibitors. J Am Chem Soc. 2024 Dec 11;146(49):33983-33996. |